RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China National Medicines Corp - Stock

China National Medicines Corp P/S 2024

China National Medicines Corp P/S

0.47

Ticker

600511.SS

ISIN

CNE000001D56

As of Jul 7, 2024, China National Medicines Corp's P/S ratio stood at 0.47, a -17.54% change from the 0.57 P/S ratio recorded in the previous year.

The China National Medicines Corp P/S history

China National Medicines Corp Aktienanalyse

What does China National Medicines Corp do?

China National Medicines Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding China National Medicines Corp's P/S Ratio

China National Medicines Corp's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing China National Medicines Corp's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating China National Medicines Corp's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in China National Medicines Corp’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about China National Medicines Corp stock

What is the price-to-earnings ratio of China National Medicines Corp?

The price-earnings ratio of China National Medicines Corp is currently 0.47.

How has the price-earnings ratio of China National Medicines Corp changed compared to last year?

The price-to-earnings ratio of China National Medicines Corp has increased by -17.54% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of China National Medicines Corp high compared to other companies?

Yes, the price-to-earnings ratio of China National Medicines Corp is high compared to other companies.

How does an increase in the price-earnings ratio of China National Medicines Corp affect the company?

An increase in the price-earnings ratio of China National Medicines Corp would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of China National Medicines Corp affect the company?

A decrease in the price-earnings ratio of China National Medicines Corp would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of China National Medicines Corp?

Some factors that influence the price-earnings ratio of China National Medicines Corp are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does China National Medicines Corp pay?

Over the past 12 months, China National Medicines Corp paid a dividend of 0.78 CNY . This corresponds to a dividend yield of about 2.54 %. For the coming 12 months, China National Medicines Corp is expected to pay a dividend of 0.86 CNY.

What is the dividend yield of China National Medicines Corp?

The current dividend yield of China National Medicines Corp is 2.54 %.

When does China National Medicines Corp pay dividends?

China National Medicines Corp pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of China National Medicines Corp?

China National Medicines Corp paid dividends every year for the past 23 years.

What is the dividend of China National Medicines Corp?

For the upcoming 12 months, dividends amounting to 0.86 CNY are expected. This corresponds to a dividend yield of 2.8 %.

In which sector is China National Medicines Corp located?

China National Medicines Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von China National Medicines Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China National Medicines Corp from 6/9/2023 amounting to 0.782 CNY, you needed to have the stock in your portfolio before the ex-date on 6/9/2023.

When did China National Medicines Corp pay the last dividend?

The last dividend was paid out on 6/9/2023.

What was the dividend of China National Medicines Corp in the year 2023?

In the year 2023, China National Medicines Corp distributed 0.7 CNY as dividends.

In which currency does China National Medicines Corp pay out the dividend?

The dividends of China National Medicines Corp are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China National Medicines Corp

Our stock analysis for China National Medicines Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China National Medicines Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.